CAS |
No.89796-99-6 |
中文名称 |
醋氯芬酸 |
英文名称 |
Aceclofenac |
别名 |
Preservex;AirtalAceclofenac |
分子式 |
C16H13Cl2NO4 |
分子量 |
354.18 |
溶解性 |
Soluble in DMSO/Ethanol ≥10mg/mL;Soluble in Water < 1mg/mL |
纯度 |
≥98% |
外观(性状) |
White to off-white Solid |
储存条件 |
Powder:2-8℃,2 years;Insolvent(母液):-20℃,6 months;-80℃,1 year |
EC |
EINECS 205-783-4 |
MDL |
MFCD00864296 |
SMILES |
O=C(OCC(O)=O)CC1=CC=CC=C1NC2=C(Cl)C=CC=C2Cl |
靶点 |
COX2 |
通路 |
Immunology & Inflammation |
背景说明 |
是一种环氧合酶2抑制剂,可用于骨关节炎,类风湿性关节炎和强直性脊柱炎的相关研究。 |
生物活性 |
Aceclofenac is an orally active nonsteroidal anti-inflammatory drug (NSAID), with analgesic and anti-inflammatory properties. Aceclofenac is used for the research of osteoarthritis, ankylosing spondylitis, rheumatoid arthritis[1-2]. |
In Vitro |
Aceclofenac(1-30 μM; 72 hours)significantly decreases interleukin-6 production and fully blocks prostaglandin E2 synthesis by IL-1β- or LPS-stimulated human chondrocytes.Aceclofenac inhibits COX-1 with IC50 values superior to 100 μM,but decreases by 50% COX-2 activity at the concentration of 0.77 μM in the whole blood test[1].Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes[2]. |
In Vivo |
Aceclofenac exhibits terminal elimination half-life(rat 3.24 h)due to high plasma clearance(rat 1.10 L/h/kg)following intravenous injection(rat 10 mg/kg)[3]. |
数据来源文献 |
[1]. Y Henrotin, et al. In vitro effects of aceclofenac and its metabolites on the production by chondrocytes of inflammatory mediators. Inflamm Res. 2001 Aug;50(8):391-9. [2]. E Maneiro, et al. Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes. J Rheumatol. 2001 Dec;28(12):2692-9. [3]. E Maneiro, et al. Keumhan Noh, et al. Absolute bioavailability and metabolism of aceclofenac in rats. Arch Pharm Res. 2015 Jan;38(1):68-72. |
规格 |
200mg 500mg 1g |
单位 |
瓶 |